List of Tables
Table 1. Global Hemoglobinopathy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hydroxyurea
Table 3. Key Players of Glutamine
Table 4. Key Players of Zynteglo
Table 5. Key Players of Other
Table 6. Global Hemoglobinopathy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hemoglobinopathy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hemoglobinopathy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Hemoglobinopathy Drugs Market Share by Region (2019-2024)
Table 10. Global Hemoglobinopathy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Hemoglobinopathy Drugs Market Share by Region (2025-2030)
Table 12. Hemoglobinopathy Drugs Market Trends
Table 13. Hemoglobinopathy Drugs Market Drivers
Table 14. Hemoglobinopathy Drugs Market Challenges
Table 15. Hemoglobinopathy Drugs Market Restraints
Table 16. Global Hemoglobinopathy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Hemoglobinopathy Drugs Market Share by Players (2019-2024)
Table 18. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Drugs as of 2023)
Table 19. Ranking of Global Top Hemoglobinopathy Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Hemoglobinopathy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemoglobinopathy Drugs Product Solution and Service
Table 23. Date of Enter into Hemoglobinopathy Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemoglobinopathy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Hemoglobinopathy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Hemoglobinopathy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Hemoglobinopathy Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Hemoglobinopathy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Hemoglobinopathy Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Hemoglobinopathy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Hemoglobinopathy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Hemoglobinopathy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Hemoglobinopathy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Hemoglobinopathy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Hemoglobinopathy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Hemoglobinopathy Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Hemoglobinopathy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Hemoglobinopathy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Hemoglobinopathy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Hemoglobinopathy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hemoglobinopathy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hemoglobinopathy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Hemoglobinopathy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Hemoglobinopathy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Hemoglobinopathy Drugs Product
Table 51. Novartis Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Hemoglobinopathy Drugs Product
Table 56. AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Bluebird Company Detail
Table 59. Bluebird Business Overview
Table 60. Bluebird Hemoglobinopathy Drugs Product
Table 61. Bluebird Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 62. Bluebird Recent Development
Table 63. Bristol-Myers Squibb Company Detail
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Hemoglobinopathy Drugs Product
Table 66. Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Emmaus Medical Company Detail
Table 69. Emmaus Medical Business Overview
Table 70. Emmaus Medical Hemoglobinopathy Drugs Product
Table 71. Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 72. Emmaus Medical Recent Development
Table 73. Acceleron Pharma Company Detail
Table 74. Acceleron Pharma Business Overview
Table 75. Acceleron Pharma Hemoglobinopathy Drugs Product
Table 76. Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 77. Acceleron Pharma Recent Development
Table 78. HemaQuest Pharmaceuticals Company Detail
Table 79. HemaQuest Pharmaceuticals Business Overview
Table 80. HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Product
Table 81. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 82. HemaQuest Pharmaceuticals Recent Development
Table 83. Eli Lilly and Company Company Detail
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Hemoglobinopathy Drugs Product
Table 86. Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Celgene Company Detail
Table 89. Celgene Business Overview
Table 90. Celgene Hemoglobinopathy Drugs Product
Table 91. Celgene Revenue in Hemoglobinopathy Drugs Business (2019-2024) & (US$ Million)
Table 92. Celgene Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemoglobinopathy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hemoglobinopathy Drugs Market Share by Type: 2023 VS 2030
Figure 3. Hydroxyurea Features
Figure 4. Glutamine Features
Figure 5. Zynteglo Features
Figure 6. Other Features
Figure 7. Global Hemoglobinopathy Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hemoglobinopathy Drugs Market Share by Application: 2023 VS 2030
Figure 9. Sickle Cell Diseases Case Studies
Figure 10. Thalassemia Case Studies
Figure 11. Hemoglobinopathy Drugs Report Years Considered
Figure 12. Global Hemoglobinopathy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Hemoglobinopathy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Hemoglobinopathy Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Hemoglobinopathy Drugs Market Share by Players in 2023
Figure 16. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemoglobinopathy Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Hemoglobinopathy Drugs Revenue in 2023
Figure 18. North America Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Hemoglobinopathy Drugs Market Share by Country (2019-2030)
Figure 20. United States Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hemoglobinopathy Drugs Market Share by Country (2019-2030)
Figure 24. Germany Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hemoglobinopathy Drugs Market Share by Region (2019-2030)
Figure 32. China Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hemoglobinopathy Drugs Market Share by Country (2019-2030)
Figure 40. Mexico Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hemoglobinopathy Drugs Market Share by Country (2019-2030)
Figure 44. Turkey Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Hemoglobinopathy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 47. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 48. Bluebird Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 50. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 51. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 52. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 54. Celgene Revenue Growth Rate in Hemoglobinopathy Drugs Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed